| Literature DB >> 25332823 |
Kenichiro Suwa1, Hiroshi Satoh2, Makoto Sano1, Mamoru Nobuhara1, Takeji Saitoh1, Masao Saotome1, Tsuyoshi Urushida1, Hideki Katoh1, Kei Tawarahara1, Hayato Ohtani1, Yasushi Wakabayashi1, Hiroyuki Takase1, Hajime Terada1, Yasuo Takehara3, Harumi Sakahara3, Hideharu Hayashi1.
Abstract
OBJECTIVE: The prognosis of apical hypertrophic cardiomyopathy (APH) has been benign, but apical myocardial injury has prognostic importance. We studied functional, morphological and electrocardiographical abnormalities in patients with APH and with apical aneurysm and sought to find parameters that relate to apical myocardial injury. STUDYEntities:
Year: 2014 PMID: 25332823 PMCID: PMC4189224 DOI: 10.1136/openhrt-2014-000124
Source DB: PubMed Journal: Open Heart ISSN: 2053-3624
Figure 1A representative patient with normal apical contraction. (A) Cine-cardiac MRIs (CMRs) at end-diastole (left) and end-systole (right). Apical hypertrophy and spade-like morphology at end-diastole and a complete disappearance of apical cavity at end-systole were shown. (B) Late gadolinium enhancement (LGE)-CMRs at short-axis view (left) and horizontal long-axis view (right). No LGE was observed. (C) Standard 12-lead ECG. High voltage QRS complexes, strain type ST depression and giant negative T waves were apparent.
Figure 2A representative patient with hypokinetic apical contraction. (A) Cine-cardiac MRIs (CMRs) at end-diastole (left) and end-systole (right). Apical hypertrophy and spade-like morphology at end-diastole were similar to those in a patient with normal apical contraction, but the apical cavity retained and did not completely disappear at end-systole (white circle). (B) Late gadolinium enhancement (LGE)-CMRs at short-axis view (left) and horizontal long-axis view (right). LGE at the left ventricular apex was apparent (white arrows). (C) Standard 12-lead ECG. In addition to giant negative T waves, fragmented QRS complexes at V3 and V4 leads were apparent (black arrows).
Figure 3A representative patient with dyskinetic apical contraction. (A) Cine-cardiac MRIs (CMRs) at end-diastole (left) and end-systole (right). The apical wall thinning, dyskinetic apical contraction and apical pouch were apparent. (B) Late gadolinium enhancement (LGE)-CMR images at short-axis view (left) and horizontal long axis view (right). LGE at the left ventricular apex was apparent (white arrows). (C) Standard 12-lead ECG. In addition to high voltage QRS complexes and giant negative T waves, fragmented QRS complexes at III, aVL and aVF leads were apparent (black arrows).
CMR parameters in patients with normal, hypokinetic and dyskinetic apical contraction
| Apical contraction | Normal | Hypokinetic | Dyskinetic | p Value |
|---|---|---|---|---|
| Number | 27 | 12 | 11 | |
| Cine-CMR | ||||
| LVEF (%) | 66.2±12.3 | 65.9±7.61 | 56.4±10.5* | 0.04 |
| LVMI (g/m2) | 63.7±26.0 | 64.6±25.4 | 87.4±25.9 | 0.05 |
| LVEDVI (mL/m2) | 60.4±16.3 | 57.7±19.0 | 66.2±12.3 | 0.44 |
| LVESVI (mL/m2) | 20.0±9.6 | 20.7±9.5 | 27.4±7.1 | 0.08 |
| Maximum LVWT (mm) | 18.3±4.2 | 19.2±5.8 | 20.3±3.8 | 0.48 |
| LGE-CMR | ||||
| LGE in any LV wall | 16 (59.3%) | 9 (75.0%) | 11 (100%) | 0.04 |
| In the apex | 11 (40.7%) | 10 (83.3%) | 11 (100%) | <0.001 |
| In other LV segments | 11 (40.7%) | 7 (58.3%) | 9 (81.8%) | 0.06 |
| Number of LGE segments | 3.5±4.9 | 2.8±2.7 | 7.0±4.2 | 0.05 |
Each value is mean±SD or number (%).
*p<0.05 vs Normal by Scheffe's post hoc analyses after one-way analysis of variance.
CMR, cardiac MR; LGE, late gadolinium enhancement; LVEDVI and LVESVI, left ventricular end-diastolic and end-systolic volume index; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; LVWT, left ventricular wall thickness.
Comparison of clinical features in terms of apical contraction
| Normal | Hypokinetic | Dyskinetic | p Value | |
|---|---|---|---|---|
| Number | 27 | 12 | 11 | |
| Age (years) | 66.0±9.84 | 62.4±11.8 | 65.5±14.1 | 0.64 |
| Male | 21 (77.8%) | 10 (83.3%) | 11 (100%) | 0.24 |
| Symptom | ||||
| Chest pain | 11 (40.7%) | 3 (25.0%) | 4 (36.4%) | 0.64 |
| Palpitation | 10 (37.0%) | 4 (33.3%) | 2 (18.2%) | 0.52 |
| Syncope | 2 (7.4%) | 2 (16.7%) | 2 (18.2%) | 0.55 |
| NYHA | ||||
| I | 22 (81.5%) | 9 (75.0%) | 8 (72.7%) | 0.81 |
| II | 5 (18.5%) | 3 (25.0%) | 3 (27.3%) | 0.81 |
| III/IV | 0 (0%) | 0 (0%) | 0 (0%) | |
| Family history | ||||
| Sudden death | 0 (0%) | 0 (0%) | 1 (9.1%) | 0.16 |
| HCM | 3 (11.1%) | 0 (0%) | 1 (9.1%) | 0.49 |
| Past history | ||||
| VT | 4 (14.8%) | 2 (16.7%) | 6 (54.5%) | 0.03 |
| SVT or Af | 9 (33.3%) | 6 (50.0%) | 3 (27.3%) | 0.48 |
| Stroke | 2 (7.4%) | 1 (8.3%) | 3 (27.3%) | 0.21 |
| NT pro-BNP (ng/mL) | 246.0 (95–1252) | 247.0 (38–603) | 262.5 (122–361) | 0.63 |
| Medication | ||||
| ACEI/ARB | 16 (59.3%) | 9 (75.0%) | 6 (54.5%) | 0.55 |
| Ca blockers | 9 (33.3%) | 6 (50.0%) | 3 (27.3%) | 0.48 |
| β-blockers | 7 (25.9%) | 7 (58.3%) | 7 (63.6%) | 0.04 |
| AAA | 2 (7.4%) | 3 (25.0%) | 2 (18.2%) | 0.31 |
| ATA | 4 (14.8%) | 2 (16.7%) | 4 (36.4%) | 0.31 |
Each value is number (%), mean±SD or median (range).
AAA, antiarrhythmic agents; ACEI, ACE inhibitors; Af, atrial fibrillation; ARB, angiotensin II receptor blockers; ATA, antithrombotic agents; HCM, hypertrophic cardiomyopathy; NYHA, New York Heart Association functional class; SVT, supraventricular tachycardia; VT, ventricular tachycardia.
Comparison of TTE parameters in terms of apical contraction
| Normal | Hypokinetic | Dyskinetic | p Value | |
|---|---|---|---|---|
| Number | 27 | 12 | 11 | |
| LVDd (mm) | 45.6±7.7 | 47.3±6.2 | 46.4±7.6 | 0.79 |
| LVDs (mm) | 27.2±5.6 | 27.7±3.9 | 29.0±4.9 | 0.61 |
| IVST (mm) | 13.8±3.4 | 13.1±2.7 | 11.6±3.7 | 0.20 |
| PWT (mm) | 12.1±2.5 | 10.9±1.5 | 10.9±2.1 | 0.14 |
| LVEF (%) | 70.9±9.4 | 72.3±8.0 | 67.7±4.6 | 0.41 |
| LVFS (%) | 40.0±7.6 | 40.2±5.0 | 37.7±3.8 | 0.55 |
| LAD (mm) | 37.1±6.5 | 39.2±5.3 | 41.2±4.9 | 0.14 |
| E/A ratio | 0.85±0.24 | 1.07±0.43 | 0.96±0.39 | 0.17 |
| DcT (ms) | 226.8±37.5 | 209.5±60.7 | 212.2±56.8 | 0.55 |
| E/e’ ratio | 15.5±4.7 | 15.5±4.7 | 13.4±4.4 | 0.45 |
Each value is mean±SD.
DcT, deceleration time of early left ventricular inflow; E/A, the ratio of E and A waves in mitral inflow velocities; E/e', the ratio of E wave and early peak of diastolic annular velocity (e'); IVST and PWT, thickness of interventricular septum and posterior wall; LAD, left atrial dimension; LVDd and LVDs, left ventricular end-diastolic and end-systolic dimensions; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; TTE, transthoracic echocardiography.
Comparison of ECG parameters in terms of apical contraction
| Normal | Hypokinetic | Dyskinetic | p Value | |
|---|---|---|---|---|
| Number | 27 | 12 | 11 | |
| HR (bpm) | 65.5±11.4 | 65.4±16.0 | 67.4±11.9 | 0.92 |
| PR (ms) | 163.7±26.9 | 173.1±38.4 | 189.6±25.4 | 0.07 |
| QRS (ms) | 100.0±15.7 | 96.7±19.9 | 102.2±7.07 | 0.69 |
| QT (ms) | 429±30.7 | 438±44.2 | 421±43.1 | 0.55 |
| QTc (ms) | 440±26.0 | 452±15.2 | 437±31.5 | 0.33 |
| Sokolow-Lyon voltage (mV) | 4.89±1.48 | 4.42±1.83 | 3.50±1.75 | 0.07 |
| Max ST (mV) | −0.14±0.18 | −0.18±0.14 | 0.02±0.18*** | 0.02 |
| Max T waves (mV) | −1.02±0.63 | −1.02±0.40 | −0.43±0.59* | 0.02 |
| fQRS | 6 (22.2%) | 7 (58.3%) | 8 (72.7%) | 0.01 |
Each value is mean±SD or number (%). *p<0.05 vs Normal, **p<0.05 vs hypokinetic by Scheffe's post hoc analyses after one-way analysis of variance.
fQRS, fragmented QRS complexes; HR, heart rate; Max ST, maximum level of ST change; Max T waves, maximum amplitude of positive or negative T waves at lateral precordial leads; QTc, corrected QT interval.
Multivariate analyses in terms of apical contraction and apical LGE
| Impaired apical contraction | |||
|---|---|---|---|
| Variables | OR | 95% CI | p Value |
| fQRS | 8.32 | 1.80 to 38.5 | 0.01 |
| PR | 1.03 | 1.00 to 1.06 | 0.04 |
| Sokolow-Lyon voltage | 0.74 | 0.44 to 1.24 | 0.22 |
| ST | 0.08 | 0.00 to 18.6 | 0.31 |
| T wave | 1.89 | 0.43 to 8.32 | 0.41 |
| Apical LGE | |||
| Variables | OR | 95% CI | p Value |
| fQRS | 8.61 | 1.51 to 49.1 | 0.02 |
| PR | 1.01 | 0.99 to 1.04 | 0.33 |
| QRS | 1.04 | 0.98 to 1.10 | 0.19 |
| ST | 26.7 | 0.13 to 5322 | 0.22 |
fQRS, fragmented QRS complexes; LGE, late gadolinium enhancement.